Hydromorphone tablets are intended to relieve moderate to severe acute pain in patients when opioid use is necessary and appropriate.
The tablets are a generic version of Stamford, Conn.-based Purdue Pharma’s Dilaudid tablets.
The India-based drug company’s new tablets represent the 12th approved treatment developed by its Dayton, N.J.-based subsidiary Aurolife.
More articles on the drug market:
Drug shortages force workarounds in Conn. hospitals
4 reasons adults need vaccines just as much as kids
Drugmakers have firm grasp on drug pricing power
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
